Description
PHARMACEUTICAL PURCHASE OF SOLARIS EXERCISE 3RD OPTION
Base award description: PHARMACEUTICAL PURCHASE OF SOLARIS
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-10-04+$25,261= $25,261
- Mod P000012013-11-05+$25,261= $50,522
- Mod P000022013-11-27+$25,261= $75,783
- Mod P000032013-12-31+$25,261= $101,044
- Mod P000042014-01-23+$21,051= $122,095
- Mod P000052014-02-05+$376= $122,471
- Mod P000062014-02-13+$451= $122,922
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-10-04 | +$25,261 | $25,261 | PHARMACEUTICAL PURCHASE OF SOLARIS |
| Mod P00001· ADDITIONAL WORK (NEW AGREEMENT,FAR PART 6 APPLI | 2013-11-05 | +$25,261 | $50,522 | PHARMACEUTICAL PURCHASE OF SOLARIS ADDITIONAL PRODUCT |
| Mod P00002· ADDITIONAL WORK (NEW AGREEMENT,FAR PART 6 APPLI | 2013-11-27 | +$25,261 | $75,783 | PHARMACEUTICAL PURCHASE OF SOLARIS - ADDITIONAL PRODUCT |
| Mod P00003· ADDITIONAL WORK (NEW AGREEMENT,FAR PART 6 APPLI | 2013-12-31 | +$25,261 | $101,044 | PHARMACEUTICAL PURCHASE OF SOLARIS EXERCISE 3RD OPTION |
| Mod P00004· ADDITIONAL WORK (NEW AGREEMENT,FAR PART 6 APPLI | 2014-01-23 | +$21,051 | $122,095 | PHARMACEUTICAL PURCHASE OF SOLARIS EXERCISE 4TH OPTION |
| Mod P00005· ADDITIONAL WORK (NEW AGREEMENT,FAR PART 6 APPLI | 2014-02-05 | +$376 | $122,471 | PHARMACEUTICAL PURCHASE OF SOLIRIS EXERCISE 4TH OPTION |
| Mod P00006· ADDITIONAL WORK (NEW AGREEMENT,FAR PART 6 APPLI | 2014-02-13 | +$451 | $122,922 | PHARMACEUTICAL PURCHASE OF SOLARIS EXERCISE 3RD OPTION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DKCXLGANZAN3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79726A0021 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24526N0739 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $104,650 | FY2026 |
| 36F79726D0143 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26026F0055 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $1,255,805 | FY2026 |
| 36C26025F0093 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $626,866 | FY2025 |
| 36C26024F0096 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $522,487 | FY2024 |
Other recipients under 6505 from 258-NETWORK CONTRACT OFFICE 18 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25816P1062 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $18,604 | FY2016 |
| VA25816E1145 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $10,361,853 | FY2016 |
| VA25816P0866 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $27,127 | FY2016 |
| VA25816J0835 | MDD US OPERATIONS, LLC | 258-NETWORK CONTRACT OFFICE 18 | $3,524 | FY2016 |
| VA25816E1024 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $9,829,900 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25814J0025_3600_V797D30015_3600 · retrieved 2026-09-26.